Effects of NMDA receptor antagonists following spinal ischemia in the rabbit

Alberto Martinez-Arizala, Donald D. Rigamonti, Joseph B. Long, Joyce M. Kraimer, John W. Holaday

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Evidence has accumulated to implicate the excitatory amino acid neurotransmitters, glutamate and aspartate, in the pathophysiology of central nervous system (CNS) ischemic injury. It appears from both in vivo and in vitro experiments that they exert their excitotoxic effects in CNS ischemia by their actions at the N-methyl-d-aspartate (NMDA) receptor complex. In the present study, we examined the effects of MK-801 and ketamine, two noncompetitive NMDA receptor antagonists, in a model of spinal cord ischemia in conscious rabbits produced by occluding the infrarenal aorta for 25 min. Five minutes after reperfusion, animals were treated with either saline, ketamine, or MK-801. By 6 h postreperfusion, all treatment groups exhibited an initial recovery of hindlimb motor function, after which the saline- and ketamine-treated groups had a similar progressive deterioration in function over the next 48 h. However, the MK-801-treated rabbits continued to recover motor function such that neurological scores in these rabbits were significantly improved relative to those of the saline-treated animals at 48 h. Histopathological evaluation showed that MK-801-treated rabbits tended to have a lesser degree of central gray matter necrosis. These results indicate that MK-801 protected against the secondary deterioration associated with this model and strengthen the potential therapeutic use of NMDA receptor antagonists in the treatment of CNS ischemia.

Original languageEnglish
Pages (from-to)232-240
Number of pages9
JournalExperimental Neurology
Volume108
Issue number3
DOIs
StatePublished - Jan 1 1990
Externally publishedYes

Fingerprint

Dizocilpine Maleate
Ischemia
Rabbits
Ketamine
Central Nervous System
Spinal Cord Ischemia
Nervous System Trauma
Excitatory Amino Acids
Therapeutic Uses
Hindlimb
Aspartic Acid
Reperfusion
Neurotransmitter Agents
Aorta
Glutamic Acid
Necrosis
aspartic acid receptor

ASJC Scopus subject areas

  • Neuroscience(all)
  • Neurology

Cite this

Effects of NMDA receptor antagonists following spinal ischemia in the rabbit. / Martinez-Arizala, Alberto; Rigamonti, Donald D.; Long, Joseph B.; Kraimer, Joyce M.; Holaday, John W.

In: Experimental Neurology, Vol. 108, No. 3, 01.01.1990, p. 232-240.

Research output: Contribution to journalArticle

Martinez-Arizala, Alberto ; Rigamonti, Donald D. ; Long, Joseph B. ; Kraimer, Joyce M. ; Holaday, John W. / Effects of NMDA receptor antagonists following spinal ischemia in the rabbit. In: Experimental Neurology. 1990 ; Vol. 108, No. 3. pp. 232-240.
@article{40463b5dc5cf419780fb2122ba453f56,
title = "Effects of NMDA receptor antagonists following spinal ischemia in the rabbit",
abstract = "Evidence has accumulated to implicate the excitatory amino acid neurotransmitters, glutamate and aspartate, in the pathophysiology of central nervous system (CNS) ischemic injury. It appears from both in vivo and in vitro experiments that they exert their excitotoxic effects in CNS ischemia by their actions at the N-methyl-d-aspartate (NMDA) receptor complex. In the present study, we examined the effects of MK-801 and ketamine, two noncompetitive NMDA receptor antagonists, in a model of spinal cord ischemia in conscious rabbits produced by occluding the infrarenal aorta for 25 min. Five minutes after reperfusion, animals were treated with either saline, ketamine, or MK-801. By 6 h postreperfusion, all treatment groups exhibited an initial recovery of hindlimb motor function, after which the saline- and ketamine-treated groups had a similar progressive deterioration in function over the next 48 h. However, the MK-801-treated rabbits continued to recover motor function such that neurological scores in these rabbits were significantly improved relative to those of the saline-treated animals at 48 h. Histopathological evaluation showed that MK-801-treated rabbits tended to have a lesser degree of central gray matter necrosis. These results indicate that MK-801 protected against the secondary deterioration associated with this model and strengthen the potential therapeutic use of NMDA receptor antagonists in the treatment of CNS ischemia.",
author = "Alberto Martinez-Arizala and Rigamonti, {Donald D.} and Long, {Joseph B.} and Kraimer, {Joyce M.} and Holaday, {John W.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1016/0014-4886(90)90128-F",
language = "English",
volume = "108",
pages = "232--240",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Effects of NMDA receptor antagonists following spinal ischemia in the rabbit

AU - Martinez-Arizala, Alberto

AU - Rigamonti, Donald D.

AU - Long, Joseph B.

AU - Kraimer, Joyce M.

AU - Holaday, John W.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Evidence has accumulated to implicate the excitatory amino acid neurotransmitters, glutamate and aspartate, in the pathophysiology of central nervous system (CNS) ischemic injury. It appears from both in vivo and in vitro experiments that they exert their excitotoxic effects in CNS ischemia by their actions at the N-methyl-d-aspartate (NMDA) receptor complex. In the present study, we examined the effects of MK-801 and ketamine, two noncompetitive NMDA receptor antagonists, in a model of spinal cord ischemia in conscious rabbits produced by occluding the infrarenal aorta for 25 min. Five minutes after reperfusion, animals were treated with either saline, ketamine, or MK-801. By 6 h postreperfusion, all treatment groups exhibited an initial recovery of hindlimb motor function, after which the saline- and ketamine-treated groups had a similar progressive deterioration in function over the next 48 h. However, the MK-801-treated rabbits continued to recover motor function such that neurological scores in these rabbits were significantly improved relative to those of the saline-treated animals at 48 h. Histopathological evaluation showed that MK-801-treated rabbits tended to have a lesser degree of central gray matter necrosis. These results indicate that MK-801 protected against the secondary deterioration associated with this model and strengthen the potential therapeutic use of NMDA receptor antagonists in the treatment of CNS ischemia.

AB - Evidence has accumulated to implicate the excitatory amino acid neurotransmitters, glutamate and aspartate, in the pathophysiology of central nervous system (CNS) ischemic injury. It appears from both in vivo and in vitro experiments that they exert their excitotoxic effects in CNS ischemia by their actions at the N-methyl-d-aspartate (NMDA) receptor complex. In the present study, we examined the effects of MK-801 and ketamine, two noncompetitive NMDA receptor antagonists, in a model of spinal cord ischemia in conscious rabbits produced by occluding the infrarenal aorta for 25 min. Five minutes after reperfusion, animals were treated with either saline, ketamine, or MK-801. By 6 h postreperfusion, all treatment groups exhibited an initial recovery of hindlimb motor function, after which the saline- and ketamine-treated groups had a similar progressive deterioration in function over the next 48 h. However, the MK-801-treated rabbits continued to recover motor function such that neurological scores in these rabbits were significantly improved relative to those of the saline-treated animals at 48 h. Histopathological evaluation showed that MK-801-treated rabbits tended to have a lesser degree of central gray matter necrosis. These results indicate that MK-801 protected against the secondary deterioration associated with this model and strengthen the potential therapeutic use of NMDA receptor antagonists in the treatment of CNS ischemia.

UR - http://www.scopus.com/inward/record.url?scp=0025293548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025293548&partnerID=8YFLogxK

U2 - 10.1016/0014-4886(90)90128-F

DO - 10.1016/0014-4886(90)90128-F

M3 - Article

C2 - 2161775

AN - SCOPUS:0025293548

VL - 108

SP - 232

EP - 240

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 3

ER -